Zobrazeno 1 - 10 of 590 pro vyhledávání: '"H, von der Maase"'
1
Screening for carcinomain situ in the contralateral testicle in patients with testicular cancer: a population-based study
Autor: Mads Agerbæk, Klaus Kaae Andersen, Kristian Almstrup, Niels V. Holm, Jakob Lauritsen, Mette Saksø Mortensen, Susanne Oksbjerg Dalton, E. Rajpert-De Meyts, Christoffer Johansen, H. von der Maase, B.G. Toft, M.G.G. Kier, N E Skakkebaek, Mikael Rørth, Gedske Daugaard
Publikováno v: Kier, M G G, Lauritsen, J, Almstrup, K, Mortensen, M S, Toft, B G, Rajpert-De Meyts, E, Skakkebaek, N E, Rørth, M, von der Maase, H, Agerbaek, M, Holm, N V, Andersen, K K, Dalton, S O, Johansen, C & Daugaard, G 2015, ' Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer : a population-based study ', Annals of Oncology, vol. 26, no. 4, pp. 737-742 . https://doi.org/10.1093/annonc/mdu585
The evaluation of a national screening programme for contralateral CIS testis in patients with unilateral testicular cancer showed that metachronous germ-cell cancers developed despite screening for CIS. Compared with unscreened patients, no signific
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02efea876b796f263e74324909b56418
https://doi.org/10.1093/annonc/mdu585
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I study
Autor: Anders Ullén, H. von der Maase, Mads Agerbæk, Helle Pappot
Publikováno v: Pappot, H, von der Maase, H, Ullén, A, Agerbæk, M & NUCOG-Nordic Urothelial Cancer Oncology Group (NUCOG) 2018, ' Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy-results of an exploratory phase I study ', Investigational New Drugs, vol. 36, no. 4, pp. 615-618 . https://doi.org/10.1007/s10637-017-0528-y
Vinflunine is to date the only registered agent for second-line treatment of metastatic urothelial cell carcinoma (UCC) in Europe. However, the effect is modest. Pemetrexed has demonstrated some single-agent activity in this disease entity. In order
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da6979b8bbdf89198b129d5467b43fcf
https://pubmed.ncbi.nlm.nih.gov/29081023
Zobrazit plný text záznamu
4
Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial
Autor: Anders Ullén, Fredrik Jäderling, Per Grybäck, Mads Agerbæk, Helle Pappot, Jeffrey Yachnin, C.-H. Shah, H. Von Der Maase, Karin Holmsten
Publikováno v: Shah, C H, Pappot, H, Agerbæk, M, Holmsten, K, Jäderling, F, Yachnin, J, Grybäck, P, von der Maase, H & Ullén, A 2019, ' Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor) : Phase I Trial ', Oncologist, vol. 24, no. 6, pp. 745-e213 . https://doi.org/10.1634/theoncologist.2018-0795
The Oncologist
Lessons Learned First trial to report safety and activity of the microtubule inhibitor vinflunine plus the tyrosine kinase inhibitor sorafenib in post-platinum metastatic urothelial cancer (mUC) patients. A recommended phase II dose was identified fo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3929a4c4a45f95a3a44374e26cc6eb
https://doi.org/10.1634/theoncologist.2018-0795
Zobrazit plný text záznamu
5
Sexuality and body image in long-term survivors of testicular cancer
Autor: Robert Zachariae, Anette Fischer Pedersen, H. von der Maase, Philip Rossen
Publikováno v: Rossen, P, Pedersen, A F, Zachariae, R & Maase, H V D 2012, ' Sexuality and body image in long-term survivors of testicular cancer ', European Journal of Cancer Prevention, vol. 48, no. 4, pp. 571-8 . https://doi.org/10.1016/j.ejca.2011.11.029
Mange mænd får seksuelle problemer efter behandling for testikelkræft, som er den mest udbredte kræftform blandt mænd i aldersgruppen 20-35 år. Det drejer sig først og fremmest om problemer med rejsning og sædafgang. Dette studie viser, at pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4146066199603a16594aa096e4fb02
https://doi.org/10.1016/j.ejca.2011.11.029
Zobrazit plný text záznamu
6
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
Autor: Niels Marcussen, Hanne Krogh Jensen, A. N. Jeppesen, Frede Donskov, H. von der Maase
Publikováno v: Jeppesen, A N, Jensen, H K, Donskov, F, Marcussen, N & von der Maase, H 2010, ' Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma ', British Journal of Cancer, vol. 102, no. 5, pp. 867-72 . https://doi.org/10.1038/sj.bjc.6605563
British Journal of Cancer
Background: Low serum sodium has recently been associated with poor survival in localised renal cell carcinoma (RCC). We now show the prognostic effect of serum sodium in patients with metastatic RCC (mRCC). Methods: Cohort A comprised 120 consecutiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7cd28832c09be350d49f7fc49a29ef
https://doi.org/10.1038/sj.bjc.6605563
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Chemotherapy-Induced Nausea, Vomiting, and Fatigue – the Role of Individual Differences Related to Sensory Perception and Autonomic Reactivity
Autor: Robert Zachariae, H. von der Maase, Anders Bonde Jensen, K. Paulsen, Mimi Mehlsen, A. Johansson
Publikováno v: Zachariae, R, Paulsen, K, Mehlsen, M Y, Jensen, A B, Johansson, A & Maase, H V D 2007, ' Chemotherapy-induced nausea, vomiting, and fatigue-the role of individual differences related to sensory perception and autonomic reactivity ', Psychotherapy and Psychosomatics, vol. 76, pp. 376-384 . https://doi.org/10.1159/000107566
Background: In spite of antiemetics, postchemotherapy side effects continue to be common and may affect compliance to cancer treatment. Among the known factors associated with increased symptom severity are: younger age, treatment toxicity, expected
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92846b6814ca68eed13749b2bd294640
https://doi.org/10.1159/000107566
Zobrazit plný text záznamu
10
A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
Autor: Poul F. Geertsen, M Kania, J. Gough, J. Lehmann, Heikki Joensuu, G. Gravis, G Chen, H. von der Maase
Publikováno v: Maase, H V D, Lehmann, J, Gravis, G, Joensuu, H, Geertsen, P F, Gough, J, Chen, G & Kania, M 2006, ' A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium ', Annals of Oncology, vol. 17, no. 10, pp. 1533-1538 . https://doi.org/10.1093/annonc/mdl154
BACKGROUND: Both pemetrexed and gemcitabine have single-agent activity in bladder cancer, but the combination of these two drugs has not been previously evaluated for safety and efficacy in this disease. Thus, the objectives in the current study were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6242c32182b246a0fe7b421074448971
https://doi.org/10.1093/annonc/mdl154
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje